ARTICLE | Clinical News
Sequus regulatory update
September 11, 1995 7:00 AM UTC
The Menlo Park, Calif., company received an approvable letter from the FDA stating that Doxil (pegyated-liposomal doxorubicin) injection is approvable for the treatment of AIDS-related Kaposi's sarcoma in patients who have failed systemic combination chemotherapy either due to disease progression or toxicity. ...